Zhengli Shi mainly investigates Virology, Coronavirus, Outbreak, Virus and Pneumonia. His studies in Virology integrate themes in fields like Severe acute respiratory syndrome coronavirus, Phylogenetics and Severe acute respiratory syndrome coronavirus 2. His Coronavirus research includes elements of Middle East respiratory syndrome coronavirus, Natural reservoir, Middle East respiratory syndrome, Coronaviridae and Pandemic.
His Outbreak research integrates issues from Transmission, Alphacoronavirus, Disease reservoir and Disease. His Virus research includes themes of Epidemiology and Fc receptor. His Pneumonia research is multidisciplinary, relying on both Angiotensin-converting enzyme 2, Innate immune system, Antibody and Pathogenesis.
His primary areas of investigation include Virology, Virus, Coronavirus, Genome and Antibody. As a part of the same scientific study, Zhengli Shi usually deals with the Virology, concentrating on Severe acute respiratory syndrome coronavirus 2 and frequently concerns with 2019-20 coronavirus outbreak. His Virus study incorporates themes from Zoology, Molecular biology and Shrimp.
Zhengli Shi combines subjects such as Horseshoe bat, Pneumonia, Alphacoronavirus, Natural reservoir and Coronaviridae with his study of Coronavirus. The various areas that Zhengli Shi examines in his Genome study include Phylogenetics, Sequence analysis, Genetic diversity and Phylogenetic tree. The study incorporates disciplines such as Recombinant DNA and Antigen in addition to Antibody.
The scientist’s investigation covers issues in Virology, Coronavirus, Virus, Severe acute respiratory syndrome coronavirus 2 and Antibody. His Virology research is multidisciplinary, relying on both Middle East respiratory syndrome coronavirus and In vitro. His Coronavirus research includes themes of Pneumonia, Middle East respiratory syndrome, Viral pneumonia, Pandemic and Viral protein.
His Pneumonia study combines topics in areas such as Viral load and Pathogenesis. His Virus research also works with subjects such as
His scientific interests lie mostly in Virology, Coronavirus, Severe acute respiratory syndrome coronavirus 2, Pneumonia and Virus. His Virology research integrates issues from Middle East respiratory syndrome coronavirus and Antibody. His research in Coronavirus intersects with topics in Vero cell, Outbreak, Middle East respiratory syndrome, Pandemic and Viral protein.
The study incorporates disciplines such as Bronchoalveolar lavage, Serology and Disease in addition to Outbreak. Zhengli Shi has included themes like Peptide sequence, In vitro, Spike Protein and 2019-20 coronavirus outbreak in his Severe acute respiratory syndrome coronavirus 2 study. His work in Pneumonia addresses subjects such as Pathogenesis, which are connected to disciplines such as Innate immune system, Angiotensin-converting enzyme 2 and Tissue tropism.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou;Xing Lou Yang;Xian Guang Wang;Ben Hu.
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Manli Wang;Ruiyuan Cao;Leike Zhang;Xinglou Yang.
Cell Research (2020)
Origin and evolution of pathogenic coronaviruses
Jie Cui;Fang Li;Zheng Li Shi.
Nature Reviews Microbiology (2019)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin;Zhenming Jin;Xiaoyu Du;Yechun Xu;Yongqiang Deng.
Bats are natural reservoirs of SARS-like coronaviruses.
Wendong Li;Zhengli Shi;Meng Yu;Wuze Ren.
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu;Hua Guo;Peng Zhou;Zheng Li Shi.
Nature Reviews Microbiology (2021)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.
Kai Duan;Bende Liu;Cesheng Li;Huajun Zhang.
Proceedings of the National Academy of Sciences of the United States of America (2020)
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.
Wei Zhang;Rong-Hui Du;Bei Li;Xiao-Shuang Zheng.
Emerging microbes & infections (2020)
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Xing Yi Ge;Jia Lu Li;Xing Lou Yang;Aleksei A. Chmura.
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.
Shuai Xia;Meiqin Liu;Chao Wang;Wei Xu.
Cell Research (2020)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: